Harvest Portfolios Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254M Buy
276,358
+28,969
+12% +$29.4M 4.19% 2
2025
Q4
$266M Sell
247,389
-31,935
-11% -$30.5M 4.62% 3
2025
Q3
$213M Buy
279,324
+117,457
+73% +$87.4M 3.93% 5
2025
Q2
$126M Buy
161,867
+35,712
+28% +$27.8M 2.93% 5
2025
Q1
$104M Buy
126,155
+3,263
+3% +$2.72M 3.08% 3
2024
Q4
$94.9M Buy
122,892
+36,587
+42% +$30.3M 3.16% 3
2024
Q3
$76.5M Buy
86,305
+20,146
+30% +$18.1M 2.54% 3
2024
Q2
$59.9M Sell
66,159
-908
-1% -$726K 2.29% 4
2024
Q1
$52.2M Sell
67,067
-26,289
-28% -$18.7M 2.04% 18
2023
Q4
$54.4M Sell
93,356
-2,600
-3% -$1.52M 2.31% 12
2023
Q3
$51.5M Sell
95,956
-16,719
-15% -$8.62M 2.43% 11
2023
Q2
$52.8M Sell
112,675
-44,842
-28% -$18.8M 2.42% 8
2023
Q1
$54.1M Buy
157,517
+30,969
+24% +$10.4M 2.65% 3
2022
Q4
$46.3M Buy
+126,548
New +$44.9M 2.66% 15

Other funds holding LLY

Harvest Portfolios Group's LLY Position: Q1 2026 in Review

Harvest Portfolios Group increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $29.4M and bringing the position to 276,358 shares worth $254M. The position accounts for 4.19% of the portfolio, ranked #2.

Harvest Portfolios Group first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $266M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Harvest Portfolios Group held 276,358 shares of Eli Lilly worth $254M as of Q1 2026.
  • Harvest Portfolios Group bought 28,969 Eli Lilly shares in Q1 2026, an estimated $29.4M.
  • Eli Lilly made up 4.19% of Harvest Portfolios Group's portfolio in Q1 2026, its #2 holding.
  • Harvest Portfolios Group first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Harvest Portfolios Group's Eli Lilly position peaked at $266M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.